News Resolutions from Novozymes A/S’ Extraordinary Shareholders’ Meeting on 30 March 2023 Staff March 30, 2023 Please read the announcement in PDF Attachment 2023_51_Novozymes_extraordinary_shareholders_meeting_resolutions Post Navigation Previous Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholdersNext Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Conference Call More Stories News CorVel Announces Effectiveness of Three-For-One Forward Stock Split Staff December 25, 2024 Cancer Clinical Trial DNA Melanoma News Pharmaceutical Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca Staff December 25, 2024 Fitness Healthcare Mental Health News Nutrition Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025 Staff December 24, 2024